Midday movers: Novavax, Nvidia, Sweetgreen rise; Moderna, Yelp fall
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Sweetgreen (SG) stock surges on revenue beat
May 10, 2024 10:58 AM EDTSweetgreen (NYSE: SG) stock surged 39% Friday, based on its latest results, which saw it top quarterly revenue expectations.
The company posted a loss per share of ($0.23), $0.05 worse than the analyst estimate of ($0.18). However, revenue for the quarter came in at $157.9 million, rising 26% year-on-year and beating the consensus estimate of $151.61... More
NVIDIA (NVDA) PT Raised to $1,350 at HSBC, 'NVL36/NVL72 server rack pricing power major driver in 2025'
May 10, 2024 10:36 AM EDTHSBC analyst Frank Lee raised the price target on NVIDIA (NASDAQ: NVDA) to $1,350.00 (from $1,050.00) while maintaining a Buy rating.
The analyst comments "Nvidias NVL36/NVL72 server rack pricing power major driver in 2025: We believe Nvidia will continue to demonstrate its strong pricing power via its NVL36/NVL72 server rack... More
SoundHound AI (SOUN) stock jumps on strong subscription demand in Q1
May 10, 2024 10:35 AM EDTSoundHound AI (NASDAQ: SOUN) shares jumped Friday on the back of its latest quarterly results, which saw it top earnings estimates.
The company's loss per share for the first quarter was ($0.07), $0.02 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $11.6 million versus the consensus estimate of $11.86 million.
Revenue grew 73% year-on-year (YoY),... More
Moderna (MRNA) says FDA delaying decision on RSV vaccine approval, shares fall
May 10, 2024 9:33 AM EDTModerna (NASDAQ: MRNA) shares are down just over 1% in early Friday trading after the company said the FDA has informed it that it will not be able to meet the May 12 PDUFA for their RSV vaccine due to "administrative... More
JPMorgan Upgrades Novavax (NVAX) to Neutral, 'Sanofi Licensing Deal Brings In Flu Heavy Weight and Lifts Going Concern'
May 10, 2024 9:27 AM EDTJPMorgan analyst Eric Joseph upgraded Novavax (NASDAQ: NVAX) from Underweight to Neutral.
The analyst comments "On the back of the announced licensing deal with Sanofi, we are upgrading Novavax shares to Neutral from Underweight. With the injection of cash upfront ($500M) removing Novavaxs going concern, , and the greater commercial heft brought to both COVID... More
